39 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares jumped 113% to $15.36 after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target.
Rezolute Presents Results From Two-Week Natural History Study In Congenital Hyperinsulinism Patients On Standard Of Care Therapies At ESPE 2021
Rezolute, Inc. (NASDAQ:RZLT), a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases associated with chronic glucose imbalance, today presented results from a natural
Roth Capital Initiates Coverage On Rezolute with Buy Rating, Announces Price Target of $21
Roth Capital analyst Zegbeh Jallah initiates coverage on Rezolute (NASDAQ:RZLT) with a Buy rating and announces Price Target of $21.
Rezolute Announces Initiation of Multiple-Ascending Dose Study of RZ402, Rezolute’s Oral PKI for Treatment of DME
Rezolute, Inc. (NASDAQ:RZLT), a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases associated with chronic glucose imbalance, today announced that the Company has
55 Biggest Movers From Friday
Gainers
IKONICS Corporation (NASDAQ: IKNX) shares surged 64.3% to close at $18.56 on Friday after the company reported a merger deal with TeraWulf.
50 Biggest Movers From Yesterday
Gainers
Verve Therapeutics, Inc. (NASDAQ: VERV) shares surged 68% to settle at $31.92 on Thursday after the company priced its IPO at $19 per share.